tiprankstipranks
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
PremiumPress ReleasesPolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
1M ago
PolyPid to hold a conference call
PremiumThe Fly
PolyPid to hold a conference call
1M ago
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
PremiumPress Releases
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
1M ago
PolyPid reports Q1 EPS ($1.37), consensus ($1.41)
PremiumThe FlyPolyPid reports Q1 EPS ($1.37), consensus ($1.41)
2M ago
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
3M ago
PolyPid to Participate in Citizens JMP Life Sciences Conference
PremiumPress Releases
PolyPid to Participate in Citizens JMP Life Sciences Conference
3M ago
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PremiumPress ReleasesPolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
5M ago
PolyPid price target lowered to $14 from $16 at H.C. Wainwright
PremiumThe Fly
PolyPid price target lowered to $14 from $16 at H.C. Wainwright
5M ago
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100